PDUFA dates and FDA Panel Review dates are very important catalysts because they are ‘make or break events’ for biotech stocks.
The goal date set by the FDA for announcing its decision on a company’s New Drug Application/ Biologics License Application/sBLA/sNDA after reviewing the applications is known as the PDUFA date.
Usually, the stocks experience a run-up going into the scheduled FDA Approval decision/FDA Panel review events. So, having prior knowledge of the key dates goes a long way toward maximizing profit or minimizing loss while investing in the volatile biotech stocks.
Listed below are large cap, mid cap and small cap stocks with pending regulatory catalysts.
Get in-depth analysis and insight on investing in the high-stakes Biotech and Pharma sectors. Check out RTT Biotech Investor and our Biotech Home Page.
ALSO READ - COVID-19 Drugs In Development Calendar which lists Companies that are in Race to find a Treatment or Vaccine for the Novel Coronavirus.
March 31, 2026 15:49 ET In this week’s video, we’ll cover major biotech moves and breakthroughs - from Novartis and Merck’s blockbuster acquisitions to the first new Hunter syndrome therapy in two decades. We’ll also look at a promising alternative to daily insulin injections and the near-term catalyst for Q3 Bio, which has been hitting new 52-week highs.
Researchers at the University of Cambridge have achieved a major milestone in vaccine development by successfully testing an artificial intelligence (AI)-designed universal coronavirus vaccine in humans for the first time. Early results show that the vaccine is safe, well tolerated, and capable of generating...
As of June 4, 2026, the United States had reported 2,030 confirmed measles cases across 40 jurisdictions, according to the Centers for Disease Control and Prevention (CDC). This figure is already close to the record 2,288 cases reported during the whole of 2025. The disease continues to spread mainly...
The Democratic Republic of Congo (DRC) saw an outbreak of Ebola last month, with a significant case count and rising death toll reported from the region. The United Nations declared a Public Health Emergency of International Concern in the DRC and Uganda, and has amplified efforts to protect vulnerable...
Park Ha Biological Technology Co., Ltd. (BYAH) announced a strategic partnership with Star Plus Action (HK) Limited, a wholly-owned subsidiary of Star Plus Legend Holdings Limited (6683.HK), to build an AI-driven skincare and health ecosystem.